ATE345355T1 - Peptidkonjugate, deren derivate mit metallischen komplexen und deren verwendung zur bildgebenden magnetischen resonanz - Google Patents

Peptidkonjugate, deren derivate mit metallischen komplexen und deren verwendung zur bildgebenden magnetischen resonanz

Info

Publication number
ATE345355T1
ATE345355T1 AT02764797T AT02764797T ATE345355T1 AT E345355 T1 ATE345355 T1 AT E345355T1 AT 02764797 T AT02764797 T AT 02764797T AT 02764797 T AT02764797 T AT 02764797T AT E345355 T1 ATE345355 T1 AT E345355T1
Authority
AT
Austria
Prior art keywords
magnetic resonance
derivatives
resonance imaging
metal complexes
peptide conjugates
Prior art date
Application number
AT02764797T
Other languages
English (en)
Inventor
Silvio Aime
Eliana Gianolio
Giancarlo Morelli
Carlo Pedone
Diego Tesauro
Luciano Lattuada
Massimo Visigalli
Pier Lucio Anelli
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Application granted granted Critical
Publication of ATE345355T1 publication Critical patent/ATE345355T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/14Peptides, e.g. proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/595Gastrins; Cholecystokinins [CCK]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02764797T 2001-08-03 2002-07-26 Peptidkonjugate, deren derivate mit metallischen komplexen und deren verwendung zur bildgebenden magnetischen resonanz ATE345355T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI001708A ITMI20011708A1 (it) 2001-08-03 2001-08-03 Coniugati di peptidi, loro derivati con complessi metallici e utilizzo per i'indagine diagnostica tramite imaging per risonanza magnetica(m

Publications (1)

Publication Number Publication Date
ATE345355T1 true ATE345355T1 (de) 2006-12-15

Family

ID=11448231

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02764797T ATE345355T1 (de) 2001-08-03 2002-07-26 Peptidkonjugate, deren derivate mit metallischen komplexen und deren verwendung zur bildgebenden magnetischen resonanz

Country Status (8)

Country Link
US (1) US20050008573A1 (de)
EP (1) EP1412383B9 (de)
JP (1) JP4216715B2 (de)
AT (1) ATE345355T1 (de)
AU (1) AU2002328981A1 (de)
DE (1) DE60216111T2 (de)
IT (1) ITMI20011708A1 (de)
WO (1) WO2003014157A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20030174A1 (it) * 2003-07-31 2003-10-29 Univ Padova Coniugati polimerici per diagnostica e terapia
ATE430146T1 (de) 2004-07-02 2009-05-15 Bracco Imaging Spa Kontrastmittel mit hoher relaxivität zur verwendung in der magnetresonanzbilddarstellung (mri), enthaltend eine chelatbildende gruppe mit polyhydroxylierten substituenten
EP1898958A2 (de) * 2005-05-31 2008-03-19 INBIOS S.r.l. Supramolekulare aggregate mit cheliermitteln und bioaktiven peptiden als effektive und selektive abgabewerkzeuge für arzneimittel und kontrastmittel bei mrt oder in der nuklearmedizin
US9339559B2 (en) 2005-09-09 2016-05-17 Georgia State University Research Foundation, Inc. Targeted contrast agents and methods for targeting contrast agents
CA2621763C (en) * 2005-09-09 2021-04-06 Georgia State University Research Foundation, Inc. Targeted contrast agents and methods for targeting contrast agents
WO2007111514A1 (en) * 2006-03-29 2007-10-04 Ge Healthcare As Contrast agents for magnetic resonance imaging and spectroscopy consisting of a cyclic oligoamid core of 3 to 4 identical monomer units with 3 to 4 paramagnetic chelate side chains
WO2008019123A2 (en) 2006-08-04 2008-02-14 Georgia State University Research Foundation, Inc. Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
US8288530B2 (en) 2006-11-06 2012-10-16 The United States Of America, As Represented By The Department Of Health And Human Services Method of preparing macromolecular contrast agents and uses thereof
WO2008076365A2 (en) 2006-12-14 2008-06-26 Georgia State University Research Foundation, Inc. Analyte sensors, methods for preparing and using such sensors, and methods of detecting analyte activity
EP2257316B1 (de) * 2008-04-02 2018-11-07 Georgia State University Research Foundation, Inc. Kontrastmittel, verfahren zur herstellung von kontrastmitteln und abbildungsverfahren
US20110038805A1 (en) * 2008-04-18 2011-02-17 Andreas Meijer Compounds comprising paramagnetic chelates arranged around a central core and their use in magneto resonance imaging and spectroscopy
ES2354320B2 (es) * 2008-06-24 2011-10-11 Universidade De Santiago De Compostela Ciclopéptidos marcados magnéticamente con complejos de lantánidos.
EP3027228B1 (de) 2013-08-01 2024-10-02 Rochester Institute of Technology Modulare kontrastmittel mit aminosäuren und peptiden
US10265014B2 (en) * 2013-09-06 2019-04-23 Somnology, Inc. System and method for sleep disorder diagnosis and treatment
US10265013B2 (en) * 2013-09-06 2019-04-23 Somnology, Inc. System and method for sleep disorder diagnosis and treatment
EP3101012A1 (de) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft Neue gadoliniumchelat-verbindung zur verwendung in der magnetresonanzbildgebung
EP3389478B1 (de) 2015-12-15 2021-03-31 Mayo Foundation for Medical Education and Research Systeme und verfahren zum linearen zeitlichen clustering für begrenzte, wiederholbare, seltene ereignisse in physiologischen signalen
JP7034160B2 (ja) 2016-11-28 2022-03-11 バイエル・ファルマ・アクティエンゲゼルシャフト 磁気共鳴画像法に使用するための高緩和度ガドリニウムキレート化合物
PE20211471A1 (es) 2018-11-23 2021-08-05 Bayer Ag Formulacion de medios de contraste y proceso para prepararlos

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111199D0 (en) * 1991-05-23 1991-07-17 Sandoz Ltd Improvements in or relating to organic compounds
US5364613A (en) * 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
GB9215780D0 (en) * 1992-07-24 1992-09-09 Univ London Pharmacy Peptide compounds
CA2113121A1 (en) * 1993-01-12 1994-07-13 Rainer Albert Peptides
GB9404208D0 (en) * 1994-03-04 1994-04-20 Nycomed Salutar Inc Chelants
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
US5762909A (en) * 1995-08-31 1998-06-09 General Electric Company Tumor targeting with polymeric molecules having extended conformation
AT405906B (de) * 1997-03-14 1999-12-27 Irene Dr Virgolini Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie
US6342598B1 (en) * 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
IT1315263B1 (it) * 1999-12-21 2003-02-03 Bracco Spa Composti chelanti,loro chelati con ioni metallici paramagnetici, loropreparazione ed uso

Also Published As

Publication number Publication date
ITMI20011708A1 (it) 2003-02-03
DE60216111D1 (de) 2006-12-28
WO2003014157A2 (en) 2003-02-20
WO2003014157A3 (en) 2003-11-13
JP2005510461A (ja) 2005-04-21
US20050008573A1 (en) 2005-01-13
EP1412383B1 (de) 2006-11-15
JP4216715B2 (ja) 2009-01-28
EP1412383B9 (de) 2007-10-03
AU2002328981A1 (en) 2003-02-24
EP1412383A2 (de) 2004-04-28
ITMI20011708A0 (it) 2001-08-03
DE60216111T2 (de) 2007-04-05

Similar Documents

Publication Publication Date Title
ATE345355T1 (de) Peptidkonjugate, deren derivate mit metallischen komplexen und deren verwendung zur bildgebenden magnetischen resonanz
PT907379E (pt) Agentes de contraste bioactivados para imagiologia de diagnostico
CY1117387T1 (el) ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ
ATE489108T1 (de) Flt4 (vegfr-3) als ziel für tumornachweis (imaging) und antitumortherapie
CY1112055T1 (el) Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα
IL168058A (en) Antibody preferentially linked to cell Ca125 / 0722p relative to ca125 / 0722p deciduous cell, the pharmaceutical composition containing it and its use in the preparation of a drug
ATE527552T1 (de) Mr-darstellungsverfahren zur diskriminierung zwischen gesundem und tumorgewebe
ATE307540T1 (de) Magnetresonanzkompatible metallische endoprothese
SE8904087D0 (sv) Peptide derivates
UY28337A1 (es) Anticuerpos humanizados que reconocen el peptido beta amiloide
ATE352567T1 (de) Herstellung von agonisten und antagonisten von cholecystokinin und ihre therapeutische und diagnostische verwendung
CY1106662T1 (el) Αντι-igf-ir αντισωματα και οι εφαρμογες τους
ATE298763T1 (de) Integrinbindende peptidderivate
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
DE60035240D1 (de) Marker für Computertomografie und MRI-Bilderzeugung
DE60136054D1 (de) Apoptose-induzierendes polypeptid
DE69837273D1 (de) Menschliches krebsantigen ny eso-1/cag-3 und dazu kodierendes gen
Nedrow et al. Positron emission tomographic imaging of copper 64–and gallium 68–labeled chelator conjugates of the somatostatin agonist Tyr3-octreotate
GEP20053423B (en) Method of Inhibiting Amyloid Protein Aggregation and Method for Imaging of Amyloid Deposits
TR200103786T2 (tr) Güğüs kanserinin tehisi ve imünoterapisi için bileşikler ve bunların kullanımı
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
ATE419861T1 (de) Peptide mit homing für lymphgefässtumor und ihre verwendung
DE59709109D1 (de) Monoklonale antikörper gegen einen komplex aus humanem act und einer serinprotease
DK1001977T3 (da) Radioaktivt mærkede peptider til diagnosen og behandlingen af bryst- og prostatatumorer samt metastaser af sådanne tumorer
ATE254130T1 (de) Makrozyclische liganden für metallpharmazeutika

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties